Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Brenda Salantes"'
Autor:
Robert F. Siliciano, Weimin Liu, Alexa N. Avitto, Michel C. Nussenzweig, Yehuda Z. Cohen, Paul M. Sharp, Michael S. Saag, Ronnie M. Russell, Luis J. Montaner, Frederic Bibollet-Ruche, Ronald G. Collman, George M. Shaw, Pierre Pellegrino, Sonya L. Heath, Julio C. C. Lorenzi, Jesse Connell, Ian Williams, Stephanie Trimboli, Andrew G. Smith, M. Alexandra Monroy, Scott Sherrill-Mix, Yingying Li, Beatrice H. Hahn, Janet M. Siliciano, D. Brenda Salantes, Lindsey J. Plenderleith, Emmanouil Papasavvas, Angharad E. Fenton-May, Julia DeVoto, Katharine J. Bar, Marina Caskey, Marcos V. P. Gondim, Persephone Borrow, Felicity Mampe
Publikováno v:
Gondim, M V P, Sherrill-Mix, S, Bibollet-Ruche, F, Russell, R M, Trimboli, S, Smith, A G, Li, Y, Liu, W, Avitto, A N, DeVoto, J C, Connell, J, Fenton-May, A E, Pellegrino, P, Williams, I, Papasavvas, E, Lorenzi, J C C, Brenda Salantes, D, Mampe, F, Alexandra Monroy, M, Cohen, Y Z, Heath, S, Saag, M S, Montaner, L J, Collman, R G, Siliciano, J M, Siliciano, R F, Plenderleith, L J, Sharp, P M, Caskey, M, Nussenzweig, M C, Shaw, G M, Borrow, P, Bar, K J & Hahn, B H 2021, ' Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption ', Science Translational Medicine, vol. 13, no. 576, eabd8179 . https://doi.org/10.1126/SCITRANSLMED.ABD8179
Sci Transl Med
Sci Transl Med
Type 1 interferons (IFN-I) are potent innate antiviral effectors that constrain HIV-1 transmission. However, harnessing these cytokines for HIV-1 cure strategies has been hampered by an incomplete understanding of their antiviral activities at later
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd61e6b06a1340de5cdaf3c9a30f3230
https://hdl.handle.net/20.500.11820/a6051f01-6cf5-434d-b22c-8486e3fd60c2
https://hdl.handle.net/20.500.11820/a6051f01-6cf5-434d-b22c-8486e3fd60c2
Autor:
Luis J. Montaner, Robert F. Siliciano, Ronnie M. Russell, Michel C. Nussenzweig, Marcos V. P. Gondim, Alexa N. Avitto, Weimin Liu, Julia DeVoto, Katharine J. Bar, Ian Williams, Persephone Borrow, Janet M. Siliciano, Jesse Connell, Ronald G. Collman, Marina Caskey, Yehuda Z. Cohen, D. Brenda Salantes, Stephanie Trimboli, M. Alexandra Monroy, Paul M. Sharp, Sonya L. Heath, Felicity Mampe, Michael S. Saag, George M. Shaw, Emmanouil Papasavvas, Angharad E. Fenton-May, Frederic Bibollet-Ruche, Julio C. C. Lorenzi, Yingying Li, Andrew G. Smith, Pierre Pellegrino, Scott Sherrill-Mix, Beatrice H. Hahn, Lindsey J. Plenderleith
Type 1 interferons (IFN-I) are potent innate antiviral effectors that constrain HIV-1 transmission. However, harnessing these cytokines for HIV-1 cure strategies has been hampered by an incomplete understanding of their anti-viral activities at later
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3bde55476e3a75454c4ddb99c93f51
Autor:
Pablo Tebas, Robert F. Siliciano, Mohamed Abdel-Mohsen, Jun Lai, E. Turner Overton, Kevin McCormick, James A. Hoxie, Randall Tressler, Scott Sherrill-Mix, Janet M. Siliciano, Jonathan Z. Li, D. Brenda Salantes, Richard A. Koup, Tuhina Srivastava, Yu Zheng, Felicity Mampe, Gerald H. Learn, Frederic D. Bushman, Subul A. Beg, Katharine J. Bar
Publikováno v:
Journal of Clinical Investigation. 128:3102-3115
BACKGROUND. The effect of a brief analytical treatment interruption (ATI) on the HIV-1 latent reservoir of individuals who initiate antiretroviral therapy (ART) during chronic infection is unknown. METHODS. We evaluated the impact of transient viremi
Autor:
Mark Mendonca, Hillary Millar Quinn, Brenda Salantes, Andriana Lebid, Katherine E. Santostefano, Christina Del Casale, Toshinobu Nishimura, Barry Morse, Marilda Beqiri, Luis Borges, Mark A. Wallet, Lucas Thompson, Sydney Bucher
Publikováno v:
Blood. 138:2771-2771
Introduction Allogenic CAR-T cell therapies for cancer provide a new option to reduce barriers faced by autologous cell therapies, but several challenges remain. One challenge is the risk of graft versus host disease (GvHD) caused by the infused T ce
Autor:
Joanne M. Russo, D. Brenda Salantes, Miguel J. Stadecker, Bridget Larkin, Nir Hacohen, Stephen C. Bunnell, Raktima Raychowdhury, Cheolho Cheong, Tae J. Yun, Laurence D. Parnell, Holly Ponichtera, Chao-Qiang Lai, Beiyun C. Liu, Mara G. Shainheit
Publikováno v:
The Journal of Immunology. 192:4655-4665
In murine schistosomiasis, immunopathology and cytokine production in response to parasite eggs are uneven and strain dependent. CBA/J (CBA) mice develop severe hepatic granulomatous inflammation associated with prominent Th17 cell responses driven b
Autor:
KaSaundra Oden, John R. Mascola, Michael Messer, Bernadette Jarocki, Barney S. Graham, James A. Hoxie, Anthony S. Fauci, Sijy O'Dell, Rebecca M. Lynch, Katharine J. Bar, Jana Blazkova, Nicole A. Doria-Rose, Mary E. Petrone, Benjamin Scheinfeld, Randall Tressler, Richard Kwan, Edward F. Kreider, Edmund V. Capparelli, Linda Harrison, Edgar T. Overton, Gerald H. Learn, Richard A. Koup, Michael C. Sneller, D. Brenda Salantes, Michael A. Proschan, Pablo Tebas, Katherine E Clarridge, Catherine Seamon, Nancy B Tustin, Robert T. Bailer, J. Shawn Justement, Julie E. Ledgerwood, Eric W. Refsland, Susan Moir, Tae-Wook Chun, Andrea Shiakolas, Mark Bardsley, Patrick J Madden
Publikováno v:
The New England journal of medicine. 375(21)
The discovery of potent and broadly neutralizing antibodies (bNAbs) against human immunodeficiency virus (HIV) has made passive immunization a potential strategy for the prevention and treatment of HIV infection. We sought to determine whether passiv
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sophia S. Kim, Brenda Salantes, Rachel E. Sutherland, Paul J. Wolters, Joanna S. Olsen, George H. Caughey
Publikováno v:
Biochemical and biophysical research communications. 450(1)
Prior work established that a deficiency in the cysteine protease dipeptidyl peptidase I (DPPI) improves survival following polymicrobial septic peritonitis. To test whether DPPI regulates survival from severe lung infections, DPPI(-/-) mice were stu